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ABSTRACT 
Decorin is the most characterized member of Small Leucine-Rich Repeat 
Proteoglycan (SLRP) family. It has been previously shown that some SLRP members 
including decorin bind to collagen type I. Binding of decorin to collagen was reported to 
inhibit collagen degradation by collagenases, suggesting that decorin might limit the 
access of collagenases to their collagen cleavage site. The amino acid sequence 
SYIRIADTNIT in decorin was reported to be the binding region to collagen type I. The 
objective of the current study was to investigate the effect of the synthetic 
SYIRIADTNIT peptide derived from the binging site of decorin (SYI peptide, hereafter) 
to collagen on MMP1-mediated collagen degradation in vitro.  
SYI peptide and its scrambled peptide were prepared. Collagen type I samples 
were incubated with various concentrations of SYI peptide and degraded by MMP1. The 
samples were subjected to electrophoresis and Coomassie Brilliant Blue (CBB) staining. 
CBB- positive collagen bands were quantified to assess the extent of collagen 
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degradation. Biotin affinity chromatography was used to identify the collagen fragment 
that the biotinylated SYI peptide binds to. Two collagen degrading enzymes; MMP1 and 
trypsin were each used to generate collagen fragments. The activity of MMP1 to degrade 
a substrate different from collagen in the presence or absence of SYI peptide was 
measured. The intensity of non-degraded collagen in the presence and absence of SYI 
peptide was compared using CBB-stained SDS-PAGE. There was no difference of 
collagen degradation in the presence or absence of SYI peptide. Collagen fibrils were 
retrieved from biotin-SYI peptide/streptavidin column, suggesting that collagen fibrils 
bind to SYI peptide. However, when collagen was treated with MMP1 or trypsin, the 
collagen fragment was not retrieved from biotin-SYI peptide/streptavidin column, 
suggesting that biotin-SYI peptide binds to collagen fibrils, but not fragments. Although 
there was no statistical difference, MMP1 activity was slightly reduced when SYI peptide 
or scrambled peptide was used at higher concentrations. 
In conclusion, there was no significant effect of SYI peptide on MMP1-mediated 
collagen degradation. SYI peptide did not act as a competitive substrate for MMP1.  
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INTRODUCTION 
 
Collagen has been widely used in the field of medicine as a biocompatible 
biomaterial. It is commonly used in medical devices, including growth factor or 
osteoinductive carriers. The carrier needs to insure controlled release of the incorporating 
factor over an extended period of time to achieve the optimum biological outcome. This 
can be achieved by manipulating the properties of the collagen and its biodegradability. 
The biodegradability of collagen is often modified by chemical or physical cross-linking. 
However, chemical cross linker reagents, such as glutaraldehyde and polyepoxy 
compounds, are cytotoxic (Ferreira, Gentile, Chiono, & Ciardelli, 2012). Physical 
treatments of collagen, such as dehydrothermal treatment, ultraviolet irradiation, gamma 
irradiation, and microwave irradiation, are efficient at introducing cross-links; however, 
collagen could be degraded by over-exposure to physical treatments. Improving the 
kinetic biodegradability of these collagen carriers by another biocompatible treatment 
may be beneficial. 
 
Collagen 
Collagen is the most abundant protein found in mammals. It constitutes the 
majority of proteins in the extracellular matrix (ECM). The fibrillar collagens, such as 
type I, form the structural framework of tissues and is responsible for tissue strength and 
integrity. Collagen type I molecules consist of two alpha-1 polypeptide chains and one 
alpha-2 polypeptide chain twisted into a triple helix. These polypeptide chains have a 
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unique amino acid sequence repeat, (Gly-X-Y)n, where X and Y are frequently the amino 
acids proline and hydroxyproline. This amino acid sequence allows hydrogen bonding 
and close packing of the three polypeptide chains along the central axis to form the 
collagen triple helical structure. 
The pathway of collagen biosynthesis has been extensively studied for fibrillar 
collagen. Figure 1 summarizes the collagen biosynthesis process. Collagen gene 
transcription and mRNA processing within the nucleus follow the general pathway for 
eukaryotic secretory protein synthesis. The two types of alpha chains, alpha-1 and alpha-
2, are formed during the mRNA translation process along the rough endoplasmic 
reticulum (RER). These peptide chains are known as preprocollagen peptides and have 
signal peptides like other secreted proteins. The signal peptides are cleaved by signal 
peptidase as the polypeptide chains emerge into the lumen of the ER, and the resulting 
polypeptide chains are known as procollagen chains (Bateman, 1996).  
The precursor form of collagen, “procollagen,” undergoes different post-
translational modifications. During progression through the membrane of the ER, 
membrane-bound enzymes, prolyl hydroxylases and lysyl hydroxylases, hydroxylate 
specific proline and lysine residues. Proline residues are hydroxylated by prolyl 4-
hydroxylase or prolyl 3-hydroxylase in the presence of oxygen, ascorbic acid, α-
ketoglutarate, and Fe2+. The ratio of 4-hydroxyproline to 3-hydroxyproline is near 100:1  
(Wu et al 2011; Myllyharju 2008). The presence of hydroxyproline is essential for the 
stability of the collagen triple helix structure at physiological temperatures (Myllyharju, 
2008). Three types of lysyl hydroxylases (LH1, LH2, and LH3) catalyze the formation of 
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hydroxylysine. LH1 primarily hydroxylates lysine residues in the helical domains of 
fibrillar and non-fibrillar collagen. LH2 was reported to be associated with lysine 
hydroxylation in the telopeptide domains of type I collagen molecules. LH3 has both 
lysine hydroxylation and sugar transferase activity; however, its LH activity may be 
related to type IV and V, but not type I collagen (Yamauchi & Sricholpech, 2012). Some 
of the hydroxylysine residues are further modified by O-linked glycosylation. This 
reaction is catalyzed by galactose transferase (GT) and galactose glucose transferase 
(GGT) activities of LH3 and produces galactosylhydroxylysine and 
glucosylgalactosylhydroxylysine (Yamauchi & Sricholpech, 2012). 
After hydroxylation and glycosylation of the pro-alpha chains, the three collagen 
molecules assemble to form the triple helix procollagen molecules, beginning from the 
carboxyl terminal end. This process is assisted by the formation of disulfide bonds 
between the cysteine residues in both carboxyl and amino terminal extensions of the 
polypeptide collagen molecules. Then, the procollagen molecules are packaged in the 
secretory vesicles, which fuse with the cell membrane, causing the release of procollagen 
molecules to the extracellular space (Bateman, 1996; Yamauchi & Sricholpech, 2012).  
In the ECM, the procollagen molecules are subjected to further post-translational 
modifications that are of greater importance, including proteolysis, fiber formation, and 
crosslinking. First, both C- and N- terminal extensions of the procollagen molecules are 
removed by procollagen N-proteinase and procollagen C-proteinase, releasing triple 
helical tropocollagen. Second, the interstitial collagen molecules orient themselves 
specifically to form collagen fibers (Last & Reiser, 1984). Third, intra- and inter-
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molecular covalent crosslinks of collagen chains are formed, which is initiated by lysyl 
oxidase, a copper-dependent enzyme. Lysyl oxidase oxidatively deaminates the amino 
group of certain lysine and hydroxylysine residues, which initiates a series of 
condensation reactions to form covalent intra- and inter-molecular cross-links. These 
reactions result in the stable covalent cross-links that are crucial for the tensile strength of 
the collagen fibers (Scott, 1988; Yamauchi & Sricholpech, 2012). 
The collagen fibrils have a repeating banding pattern along the fiber axis when 
visualized by transmission electron microscopy, designated a-e bands in the collagen D-
period (Scott, 1988). This pattern results from packing the collagen molecules into a 
staggered overlap arrangement; the molecules are packed side by side with adjacent 
molecules staggered along their axis by a fixed distance. According to a simple model, 
bands d and e are located at the gap between the ends of the collagen molecules and 
alternate with band b, located in the overlap zone, while bands a and c are at the step to 
the gap zone.  
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Figure 1. Collagen biosynthesis and formation of mature collagen. Collagen type I 
alpha chains undergo post-translational modifications. Specific proline and lysine 
residues are hydroxylated by prolyl hydroxylases (PH) and lysyl hydroxylases (LH), 
respectively. Some of the hydroxylysine residues are further modified by glycosylation. 
This reaction is catalyzed by galactose transferase (GT) and galactose glucose transferase 
(GGT) activities of LH3. Then, the three alpha chains are folded into triple helical 
structure. The triple helical procollagen molecules are secreted to the ECM and then both 
N- and C-terminal extensions are cleaved by procollagen N-proteinase and procollagen 
C-proteinase to form mature type I collagen. The interstitial collagen molecules orient 
themselves specifically to form collagen fibers. The collagen molecules are further 
stabilized by the formation of intra- and inter-molecular covalent crosslinks, which is 
initiated by the lysyl oxidase enzyme (LOX) (Kaku & Yamauchi, 2014).  
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Matrix Metalloproteinases (MMPs) 
MMPs are the major enzymes hydrolyzing ECM proteins. There are twenty three 
MMPs in humans (H Nagase & Woessner, 1999; Hideaki Nagase, Visse, & Murphy, 
2006), which play central roles in morphogenesis, wound healing, tissue repair, and 
remodeling in response to injury. The typical structure of MMPs consists of a pro-
domain, a catalytic domain, and a hemopexin domain. The pro-domain contains the 
cysteine switch motif (PRCXXPD, where P is proline, R is arginine, C is cysteine, D is 
aspartate, and X is any amino acid), and the catalytic domain contains the zinc binding 
motif (HEXXHXXGXXH, where H is histidine, E is glutamic acid, G is glycine, and X is 
any amino acid) (Bode, Gomis-Rüth, & Stöckler, 1993). These motifs are common 
structural signatures of MMPs, where the cysteine residue of the pro-domain coordinates 
to three histidine residues in the zinc binding motif of the catalytic domain. This cysteine-
zinc coordination maintains the enzyme in an inactive state until removal of the pro-
domain by proteolysis or destabilization renders the enzyme active. The catalytic domain 
also contains a conserved methionine, forming the “Met-turn” eight residues after the 
zinc binding motif. Located C-terminal to the Met-turn, the hemopexin domain facilitates 
substrate recognition (Hideaki Nagase et al., 2006; Paladini et al., 2013) (Figure 2).  
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Figure 2. Domain structures of the MMP family. sp, signal peptide; pro, pro-domain; 
cat, catalytic domain, FNII, fibronectin type II motif; L1, linker 1; Hpx, hemopexin 
domain; L2, linker 2; Mb, plasma membrane; TM, transmembrane domain; Cy, 
cytoplasmic tail; CysR, cysteine rich; Ig, immunoglobulin domain; GPI, 
glycosylphosphatidylinositol anchor (Hideaki Nagase et al., 2006). 
 
 
MMPs are synthesized as pre-proenzymes and secreted from the cells as pro-
MMP after removal of the signal peptide. Therefore, activation of MMPs is an important 
regulatory step of their activity. Removal of the propeptide by tissue and plasma 
proteinases, opportunistic bacterial proteinase, or other active MMPs renders the enzyme 
active (H. Nagase, Enghild, Suzuki, & Salvesen, 1990; Hideaki Nagase et al., 2006). 
Other pro-MMPs are activated intracellularly by proprotein convertases and secreted or 
cell surface-bound as active enzymes (Hideaki Nagase, 2001; Remacle, 2003). 
In the laboratory setting, many MMPs are readily activated by treatment with 
sulfhydryl reagents, such as heavy metals, iodoacetamide, and mercury compounds 
(Galazka, Windsor, Birkedal-Hansen, & Engler, 1996). Activation of pro-MMP is 
believed to occur by dissociation of the sulfhydryl group of the cysteine from the zinc site 
and its replacement with a water molecule, as predicted by the cysteine switch model. 
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Pro-MMP can also be activated by detergents or chaotropic agents, which induce 
conformational changes in the polypeptide chain (Birkedal-Hansen & Taylor, 1982; 
Galazka et al., 1996; Stricklin, Jeffrey, Roswit, & Eisen, 1983). Pro-MMP can also be 
activated by limited cleavage of the propeptide by proteolytic enzymes, such as trypsin or 
chymotrypsin (Galazka et al., 1996; Okada, Gonoji, Nakanishi, Nagase, & Hayakawa, 
1990; Stricklin et al., 1983). Moreover, MMP activities are regulated by two major types 
of endogenous inhibitors, a2-macroglobulin and tissue inhibitor of metalloproteinases 
(TIMPs). a2-Macroglobulin primarily regulates MMP activities in the fluid phase and 
inhibits most MMPs by entrapping the proteinase within the macroglobulin, after which 
the complex is cleared by endocytosis. TIMPs inhibit MMPs by binding to their active 
sites, chelating the catalytic zinc atom and rendering the enzyme inactive (Hideaki 
Nagase et al., 2006). Additionally, several MMP inhibitors have been discovered and 
investigated during the past years, such as Marimastat and sulfonamide-based 
hydroxamic acid derivatives (Bertini et al., 2004; Hanessian, Moitessier, Gauchet, & 
Viau, 2001; Jeng, Chou, & Parker, 1998).   
MMPs are grouped into subfamilies based on domain organization and substrate 
preference, such as collagenases, gelatinases, stromelysins, matrilysins, and others. 
Collagenases are characterized by their abilities to cleave triple-helical interstitial 
collagen. This MMP subfamily includes MMP1 (interstitial collagenase/collagenase 1), 
MMP8 (neutrophil collagenase/collagenase 2), and MMP13 (collagenase 3). Each 
collagenase exhibits a preference for different collagen types. Based on kinetic studies of 
degradation of different collagen types from different species origins, human MMP1 
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prefers to digest human collagen types I and III rather than type II, whereas MMP13 
degrades collagen type II more readily than MMP1 or MMP8 (Hasty, Jeffrey, Hibbs, & 
Welgus, 1987; Welgus, Jeffrey, & Eisen, 1981b). MMP1 degradation of a particular 
collagen type may depend on species (Hasty et al., 1987; Welgus et al., 1981b).  
Collagenases catalyze the cleavage of interstitial collagen types I, II, and III at the 
peptide bond between Gly775 and Ile776 or Gly775 and Lys776 (Welgus, Jeffrey, & 
Eisen, 1981a). This cleavage results in the generation of the characteristic 3/4 and 1/4 
fragments. These fragments denature into gelatin at physiologic temperature. Then, 
further breakdown of collagen is catalyzed by less specific proteinases (Van Doren, 
2015).  
 
Small Leucine-Rich Repeat Proteoglycans (SLRPs) 
Proteoglycans are composed of covalently linked diverse chains called 
glycosaminoglycans (GAGs) attached to serine residues of a protein core (Schaefer & 
Schaefer, 2010). GAGs are long unbranched polysaccharides of repeating units of 
disaccharide. The disaccharide unit mostly consists of N-acetylglucosamine or N-
acetylgalactosamine attached to a uronic sugar or galactose (Esko, Kimata, & Lindahl, 
2009). Owing to their polarity, GAGs enable proteoglycans to bind water and extend in 
conformation, conferring their hydrating and shock absorbing functions. In addition to 
GAGs, most proteoglycans also have N- and/or O-linked oligosaccharides (Kjeuin & 
Lindahl, 1991). Proteoglycans are categorized by their relative size and the type of their 
GAG chains. The large proteoglycan family includes twenty-five members (Iozzo & 
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Schaefer, 2015). For example, aggrecan and perlecan are relatively large proteoglycans 
with multi-domain assemblies. On the other hand, certain proteoglycans with relatively 
smaller protein cores are considered members of the small leucine-rich repeat 
proteoglycans (SLRPs). 
SLRPs are a family of proteins characterized by a core protein with multiple 
leucine-rich repeat (LRR) structural motifs covalently linked to glycosaminoglycan side 
chains and flanked by cysteine-rich clusters on the N- and C- termini (Geng, McQuillan, 
& Roughley, 2006; Merline, Schaefer, & Schaefer, 2009). Each LRR consists of 20-29 
amino acids, commonly 24 residues, with a conserved eleven amino acid hallmark 
sequence of LxxLxLxxNxL, where L is leucine, or can be substituted by isoleucine, 
valine, and other hydrophobic amino acids, and x is any amino acid (McEwan, Scott, 
Bishop, & Bella, 2006). At the N-terminus, all SLRPs have many cysteine residues with 
class-conserved internal spacing (Chen & Birk, 2013). Another feature of SLRPs is the 
presence of a long laterally extending repeat at the C-terminus of certain classes, called 
‘ear repeat’ (Chen & Birk, 2013).  
SLRPs are now classified into five distinct families based on conservation and 
homology at genomic and protein levels and the presence of a characteristic Cys-rich 
cluster at the N-terminus of the core protein (Iozzo & Schaefer, 2015; Mochida et al., 
2011; Tillgren, Ho, Önnerfjord, & Kalamajski, 2015) (Table 1). The SLRPs are closely 
related, but they differ in expression and acquired functions (Kalamajski & Oldberg, 
2010). 
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Class I Decorin  
Biglycan 
Asporin 
Class II Lumican 
Fibromodulin 
PRELP 
Keratocan 
Osteomodulin 
Class III Opticin 
Epiphycan 
Osteoglycin 
Class IV Chondroadrerin 
Chondroadherin-like (CHADL)  
Nyctalopin 
 Nephrocan 
 Podocan 
 Podocan-like 
 TSK 
Table 1. Classification of Mouse SLRP Members. PRELP, proline/arginine-rich end 
leucine-rich repeat protein; TSK, tsukushi. Adopted from (Mochida et al., 2011; Tillgren 
et al., 2015).   
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One of the molecular functions of SLRPs is to modify the deposition and 
arrangement of collagen fibrils through their interaction in the ECM (Sylvester & Ratner, 
2017). SLRPs also interact with different components of the ECM, leading to modulation 
of cellular functions. For example, decorin, biglycan, asporin, and fibromodulin bind to 
TGF-β (Hildebrand et al., 1994). Also, biglycan is capable of binding to BMP-4 and 
modulates its activity (Nakajima et al., 2007). 
Binding to collagen is a prominent feature of some SLRPs. Decorin is the most 
extensively studied member of the SLRP family and is well documented to bind to 
collagen type I (Svensson, Oldberg, & Heinegård, 2001; Vogel, Paulsson, & Heinegård, 
1984). Moreover, as listed in Table 1, biglycan, asporin, fibromodulin, lumican, 
osteoglycin, and podocan were also reported to bind to collagen type I (Chen & Birk, 
2013; Hedbom & Heinegard, 1989; Kalamajski & Oldberg, 2010; Rada, Cornuet, & 
Hassell, 1993).    
Decorin is the most characterized member of the SLRPs. It belongs to class I of the 
SLRPs, with a defined N-terminal cysteine sequence (CX3CXCX6C, where C is cysteine, 
and X is any amino acid) that forms two disulfide bonds (Ameye & Young, 2002). The 
mature protein is highly conserved across species. Its core protein is around 45 kDa in 
size and is composed of twelve LRRs (numbered I-XII), each containing an average of 
twenty-four amino acid residues. The LRR region is flanked by disulfide-bonded terminal 
sequences from both sides. Close to the N-terminus, decorin is linked to a single GAG 
chain, chondroitin or dermatan sulfate, whereas the central domain contains three 
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attachment sites for N-linked oligosaccharides (Weber, Harrison, & Iozzo, 1996) (Figure 
3).  
 
 
 
Figure 3. Schematic diagram of decorin. LRRs shown as orange boxes in the domain 
of the core protein, flanked by cysteine-rich clusters on both sides that can form disulfide 
bonds (red boxes). Decorin carries one dermatan sulfate or chondroitin sulfate 
glycosaminoglycan in the N-terminal region, marked by the yellow triangle. The green 
lines indicate potential N-linked glycosylation sites, Adapted from (Islam, 2014).  
 
 
Based on the interaction of decorin core protein with other proteins in the ECM, 
several important functions have been attributed to decorin, including regulation of 
collagen fibrillogenesis. Decorin has a role in delaying fibril assembly and reducing fibril 
diameter (Chen & Birk, 2013; Kalamajski & Oldberg, 2010). Decorin has been shown to 
bind to different types of collagen, such as type I, II, III, VI and XIV (Bidanset, 1992; 
Douglas, 2006; Vogel, 1984).  
The structural elements of decorin that bind to collagen type I have been studied. 
A previous study analyzed the decorin core protein, showing that neither the N-terminal 
half nor the central LRR repeats of decorin core protein can, by themselves, bind to 
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fibrillar collagen (Pogány & Vogel, 1992; Van Wart & Birkedal-Hansent, 1990). Another 
study reported that decorin binds to collagen type I primarily via LRR 4-5 (Svensson, 
Heinegard, & Oldberg, 1995), and a later report identified LRR 6 (Met-176 – Lys-201) to 
be important for the binding of decorin to collagen (Kresse, 1997). Recently, Kalamajeski 
et al demonstrated that LRR 5-6 of decorin, encompassing Arg-207 and Asp-210, is 
essential for collagen binding. Their data also showed that the Glu-181 residue, which 
was previously shown to be essential for collagen interaction, was not directly involved 
in the binding site, but its mutation might lead to mis-folding or structural changes in the 
collagen-binding site of the full-length decorin. These three amino acids, Arg-207, Asp-
210, and Glu-181, were shown to be conserved in fifteen species, emphasizing their 
structural role and involvement in collagen binding (Kalamajski, Aspberg, & Oldberg, 
2007). Moreover, in the same report by Kalamajeski, the binding region of decorin to 
collagen type I could be further localized to the specific sequence SYIRIADTNIT (SYI 
peptide) (Kalamajski et al., 2007) (Figure 4). In a solid-phase collagen binding assay, 
SYI peptide was reported to inhibit decorin-collagen interaction, whereas collagen-
fibromodulin interaction was unaffected. Therefore, in this report, SYI peptide was 
documented to bind collagen and compete with the full length decorin for the same 
collagen binding site (Kalamajski et al., 2007).  
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Figure 4. The structure and amino acid sequence of decorin. (A). A diagram of 
decorin LRR domain structure. The roman numbers correspond to the LRRs. Green 
arrows, b-strands; red ribbons, a-helical turns; pink tubes, segments of polyproline II 
helix; orange ribbons, short segments of 310 helices and b-turns; yellow sticks, disulfide 
bonds (Scott et al, 2004). (B). Amino acid sequence of house mouse decorin with internal 
organization of LRRs. Yellow highlight, SYI peptide, Adapted from (Scott et al, 2004).   
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Collagen and Decorin Interaction 
The presence of decorin on the surface of the collagen fibrils was suggested to 
inhibit collagen fibril degradation by collagenases (Geng et al., 2006). It was suggested 
that the binding of decorin to the surface of collagen fibrils may form a barrier, possibly 
limiting the access of collagenase to its collagen cleaving site, which could lead to the 
protection of collagen by inhibiting its degradation (Geng et al., 2006). Since SYI peptide 
is derived from the collagen binding site of decorin, and its binding to collagen and 
competition with decorin at the same collagen binding site have been documented 
(Kalamajski et al., 2007), it is feasible that SYI peptide binding to collagen may also 
inhibit collagen degradation by collagenases. This inhibition of collagenase degradation 
could occur either by limiting the access of collagen degrading enzymes to their collagen 
cleavage site or by diverting these enzymes to degrade SYI peptide rather than the 
collagen molecule. Therefore, SYI peptide could modify the properties and 
biodegradability of collagen.   
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HYPOTHESIS 
 
Binding of SYI peptide to collagen may inhibit MMP1-mediated collagen type I 
degradation.  
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AIMS 
 
1. Investigate the effect of decorin-derived synthetic peptide SYIRIADTNIT in 
inhibiting MMP1-mediated collagen degradation in vitro. 
2. Investigate the binding of decorin-derived synthetic peptide SYIRIADTNIT to 
collagen and determine its binding site(s) on collagen. 
3. Investigate the effect of decorin-derived synthetic peptide SYIRIADTNIT on the 
activity of MMP1.  
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METHODS AND EXPERIMENTAL DESIGNS 
 
MMP1-Collagen Degradation Assay 
Pepsin-extracted acid-solubilized collagen type I (PureCol, Catalog #5005-
100ML (formerly #5005-B), Advanced BioMatrix, San Diego, USA) was incubated in 
Tris buffer (50 mM Tris-HCl, 150 mM NaCl, 10 mM CaCl2, pH 7.5) at a concentration of 
2 µM overnight at 4 °C to form collagen fibril solution. Four samples were prepared from 
the prepared collagen fibril solution. 
MMP1 (R&D systems, 901-MP-010, Minneapolis, MN, USA) at a concentration 
of 541.5 nM was incubated in Tris buffer (50 mM Tris-HCl, 150 mM NaCl, 10 mM 
CaCl2, pH 7.5) containing 0.5 mM p-Aminophenylmercuric Acetate (APMA) for 30 min. 
at 37 °C for MMP1 activation. Immediately, the activated MMP1 was added at final 
concentrations of 38, 76, and 152 nM to the collagen samples, in a total volume of 80 µl 
per sample. The samples were incubated overnight at 37 °C. A sample of collagen only 
without MMP1 was included as a control.  
For collagen cleavage analysis, SDS sample buffer was added to each sample. 
Then, 50 µl from each sample was loaded on SDS-PAGE NuPAGE 4-12% Bis-Tris gel 
(Invitrogen). To visualize proteins, including collagen and its degraded fragments, SDS-
PAGE was stained with Coomassie Brilliant Blue (CBB).  
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The Effect of SYI Peptide on MMP1-Mediated Collagen Degradation 
Collagen type I fibril solution was formed by mixing 100 µl collagen (3 µg/µl in 
0.01 M HCl) with Tris Buffer (50 mM Tris-HCl, 150 mM NaCl, 10 mM CaCl2, pH 7.5) 
overnight at 4 °C. Eight samples were prepared from the collagen fibril solution. The 
samples were incubated with various concentrations of SYI peptide or its scrambled 
peptide IYITDRNSTIA, 0.006, 0.02, 0.05, and 0.17 mM, overnight at 37 °C. 
MMP1 was activated by incubation with 0.5 mM APMA in Tris buffer for 30 
min. at 37 °C. Immediately, the activated MMP1 was added to the samples to a final 
MMP1 concentration of 76 nM. A control sample of collagen was incubated with MMP1 
without previous incubation with any peptide. The other control of collagen was 
incubated alone without incubation with neither peptide nor MMP1. The samples were 
incubated overnight at 37 °C.  
For collagen cleavage analysis, SDS sample buffer was added to each sample. 
Then, 50 µl from each sample was loaded on SDS-PAGE NuPAGE 4-12% Bis-Tris gel. 
To visualize proteins, including collagen and its degraded fragments, SDS-PAGE was 
stained with CBB.  
The non-degraded collagen in each sample, including alpha-1 chain, alpha-2 
chain, and the multi-form collagen, was quantified using ImageJ software program as 
shown in Figure 6 B. The intensity of non-degraded collagen obtained from the control 
sample, in which collagen alone was loaded on SDS-PAGE was considered as the total 
collagen. The percentage of non-degraded collagen to the total amount of collagen was 
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calculated for each sample. The percentage of non-degraded collagen for the samples 
were compared to evaluate the extent of collagen degradation.  
The same experimental procedure was performed using higher SYI peptide 
concentrations, 0.25, 0.5, 1, 2 mM.  
The synthetic SYI peptide (SYIRIADTNIT) was obtained from Peptide 2.0, Inc. 
The scrambled peptide (IYITDRNSTIA) was designed using Peptide 2.0 software 
program and obtained from Peptide 2.0, Inc.  
 
Biotin Affinity Chromatography to Identify the Collagen Sequence that Binds SYI 
Peptide Using MMP1 and Trypsin as Collagen Degrading Enzymes 
 
Biotin Affinity Chromatography to Identify Non-Degraded Collagen that Binds Biotin-
SYI Peptide (A Control Experiment) 
Sreptavidin sepharose packed columns were used to separate the non-degraded 
collagen that binds biotin-SYI peptide. The experimental column was equilibrated by 
adding 400 µl binding buffer, TBS (50 mM Tris, 150 mM NaCl, pH 7.5) and centrifuged 
for 1 min. at 150 rcf. These steps were repeated three times. Immediately after the 
equilibration, 360 µg biotin-SYI peptide dissolved in 30% dimethyl sulfoxide (DMSO) 
(200 µl) was added to the column and incubated with slow end-over-end shaking for 30 
min. at room temperature. Then, unbound biotin-SYI peptide was removed by 
centrifuging for 1 min. at 150 rcf. The column was washed three times with 30% DMSO, 
followed by washing three times with the binding buffer, TBS (pH 7.5). After washing, 
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200 µl of the collagen fibril solution (2 µM), prepared as described above, was added to 
the column and incubated with rotating overnight at 37 °C. The unbound collagen was 
removed by centrifugation for 1 min. at 150 rcf. The flow-through was collected. Then, 
the column was washed with 400 µl of the washing buffer (TBS, 2 M urea, pH 7.5) for 
four times, and the flow-through was collected from each wash separately. After 
washing, the column was eluted with 200 µl of the elution buffer (0.1 M glycine, 2 M 
urea, pH 2.9, according to the manufacturer’s protocol) and centrifuged for 1 min. at 
1,000 rcf. The elution was performed three times and the elution solution was collected 
separately each time. The same proportions of the unbound collagen flow-through, the 
washing flow-through, and the elution solutions were loaded on SDS-PAGE. To visualize 
proteins, including collagen, SDS-PAGE was stained with CBB. Two other columns 
were used as controls, prepared as follows:  
• A column loaded with the collagen fibril solution only, without any previous 
peptide loading. 
• A column loaded with biotin-scrambled peptide instead of biotin-SYI peptide and 
then with the prepared collagen fibril solution.  
Both control columns were centrifuged, washed, and eluted in the same manner as 
the experimental column. 
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Biotin Affinity Chromatography to Identify the Collagen Sequence that Binds Biotin-SYI 
Peptide Using MMP1 as a Collagen-Degrading Enzyme 
 
Preparation of collagen fibril solution: The collagen fibril solution was prepared 
as described above in the MMP1-mediated collagen degradation assay with 2 µM 
collagen. 
Preparation of the MMP1-mediated collagen degradation solution: MMP1 was 
activated by incubating with 0.5 mM APMA in Tris buffer for 30 min. at 37 °C. 
Immediately following activation, MMP1 was added to the collagen fibril solution and 
incubated overnight at 37 °C.  
Separation of the MMP1-degraded collagen fragment that binds biotin-SYI 
peptide: Streptavidin sepharose packed columns were used to separate the collagen 
sequence that binds biotin-SYI peptide. The experimental column was equilibrated and 
loaded with biotin-SYI peptide in the same manner as described previously in the control 
experiment (page 21). Then, 200 µl of the prepared MMP1-degraded collagen solution 
was added to the column and incubated with shaking overnight at 37 °C. The unbound 
collagen was removed by centrifuging for 1 min at 150 rcf. The flow-through was 
collected. Then, the column was washed with 400 µl of the washing buffer (TBS, 2 M 
urea, pH 7.5) three times, and the flow-through was collected separately each time. After 
washing, the column was eluted with 200 µl of the elution buffer (0.1 M glycine, 2 M 
urea, pH 2.9) and centrifuged for 1 min. at 1,000 rcf. The elution was performed three 
times and the elution solution was collected each time separately. The same proportions 
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of the unbound collagen flow-through, the washing flow-through, and the elution 
solutions were loaded on SDS-PAGE and stained with CBB.  
Two more columns were used as controls, described as follows:  
• A column loaded with the MMP1-degraded collagen solution only. 
• A column loaded with biotin-scrambled peptide instead of biotin-SYI peptide and 
then with the prepared MMP1-degraded collagen solution. 
Both control columns were centrifuged, washed, and eluted in the same manner as 
the experimental column.   
 
Biotin Affinity Chromatography to Identify the Collagen Sequence that Binds Biotin-SYI 
Peptide Using Trypsin as a Collagen Degrading Enzyme 
Degradation of collagen with trypsin: In order to optimize the collagen to trypsin 
ratio, non-fibrillized collagen solution, which likely contains monomer collagen 
molecule, was incubated with various concentrations of trypsin (Promega), 0.43, 0.86, 
and 1.72 µM, in 50 mM Tris buffer. Non-fibrillized collagen was used as trypsin is not a 
physiological enzyme for collagen and does not require the presence of collagen fibril 
form to degrade it. The final concentration of collagen was 1 µM per sample. The 
samples were incubated overnight at 37 °C. A sample of collagen only without trypsin 
was included as a control. 
SDS sample buffer was added to each sample. Then, 50 µl from each sample was 
loaded on SDS-PAGE. To visualize collagen and its degraded fragments, SDS-PAGE 
was stained with CBB.  
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Preparation of trypsin-degraded collagen solution: Trypsin-digested collagen 
solution was prepared for the affinity chromatography experiment by incubating non-
fibrillized collagen with trypsin at a ratio of 20:1 in 50 mM Tris buffer overnight at 37 
°C. After the incubation, trypsin activity was inhibited by adding 100 µM Tosyl-L-lysyl-
chloromethane hydrochloride (TLCK) (Abcam) and incubating the solution for one hour 
at room temperature.  
Separation of the trypsin-degraded collagen fragment that binds biotin-SYI 
peptide: The same experimental procedure was performed as described for the separation 
of the MMP1-degraded collagen fragment that binds biotin-SYI peptide except that the 
column was loaded with trypsin-degraded collagen solution instead of MMP1-degraded 
collagen solution.  
Four columns were used as controls, described as follows: 
• A column loaded with biotin-SYI peptide and then with the non-fibrillized 
collagen solution.  
• A column loaded with the non-fibrillized collagen solution only. 
• A column loaded with the trypsin-digested collagen solution only. 
• A column loaded with biotin-scrambled peptide instead of biotin-SYI peptide and 
then with the prepared trypsin-digested collagen solution.  
• A column loaded with biotin-SYI peptide and then with trypsin alone, without 
collagen. 
All control columns were centrifuged, washed, and eluted in the same 
manner as the experimental column.  
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MMP1 Activity Assay 
The activity of MMP1 was measured using a MMP1 inhibitor screening kit 
(Abcam), which utilizes a thiopeptide as a chromogenic substrate. Hydrolysis of the 
thiopeptide by MMP1 produces a sulfhydryl group, which reacts with 5,5’-dithiobis(2-
nitrobenzoic acid) (DTNB) to form 2-nitro-5-thiobenzoic acid, which can be detected by 
its absorbance at 420 nm. The assay was performed using a 96-well microplate. SYI 
peptide at concentrations of 0.023, 0.07, 0.23, and 0.7 mM, dissolved in urea, were 
incubated with 20 µl MMP1 (153 mU/µl) in the assay reaction buffer. MMP1 inhibitor, 
N-Isobutyl-N-(4-methoxyphenylsulfonyl)-glycylhydroxamic acid (NNGH), was 
incubated with MMP1 as a positive control at a final concentration of 1.3 µM. Another 
control was incubating MMP1 with neither SYI peptide nor MMP1 inhibitor. The volume 
was adjusted to 90 µl per well. The urea concentration was 2 M in each sample. The 
microplate was incubated for 30 min. at 37 °C to allow peptide or inhibitor/MMP1 
interaction. Then, the reaction was started by addition of the thiopeptide substrate (10 µl). 
The final concentration of the thiopeptide substrate was 100 µM per well. The optical 
densities (ODs) of the samples were recorded at 420 nm every 3 minutes for 30 minutes. 
A standard enzyme progress curve was prepared based on the OD and time according to 
the manufacturer's protocol.  
 
Statistical analysis 
 One-way ANOVA with Tukey post-hoc test was used to evaluate the statistical 
significance between the samples. P value with less than 0.05 was considered significant.  
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RESULTS 
 
The Effect of SYI Peptide on MMP1-Mediated Collagen Degradation 
Collagen type I was used in the current study because it is the major protein in bone 
and dentin. In mammals, collagenases include MMP1, MMP8, and MMP13. Previous 
report which investigated the effect of decorin on collagen degradation by collagenases 
mainly used MMP1 (Geng et al., 2006); therefore, MMP1 was used in the current study.  
In order to optimize the collagen type I to MMP1 ratio that would be used in the 
subsequent experiments, 2 µM collagen type I samples were incubated with various 
concentrations of MMP1 (38, 76, and 152 nM). Then, the samples were applied to SDS-
PAGE. To visualize proteins, including collagen, SDS-PAGE was stained with CBB 
(Figure 5). Collagen alone, without MMP1, served as a control. Two positively stained 
bands were observed at around 150 kDa and 140 kDa, corresponding to collagen alpha-1 
and alpha-2 chains, respectively. Positively stained bands migrating higher than 150 kDa 
were also observed, corresponding to a-dimeric and a-trimeric forms of collagen. When 
collagen type I samples were incubated with various concentrations of MMP1, positively 
stained bands were observed at around 127 kDa and 40 kDa (Figure 5, lanes 2-4), 
corresponding to the three quarters and one quarter collagen degraded fragments. As the 
MMP1 concentration was increased, the amount of non-degraded collagen appeared to 
decrease and that of the degraded collagen fragments appeared to increase. In the absence 
of MMP1 incubated with collagen, only positively stained bands corresponding to alpha-
1, alpha-2, and multi-form collagen were observed (Figure 5, lane 1). Therefore, the 
  28 
results indicate that MMP1 appears to degrade collagen type I in a dose-dependent 
manner. Incubation of collagen type I with 76 nM MMP1 (Figure 5, lane 3) was selected 
for subsequent experiments because the amount of MMP1 appeared to be sufficient for 
collagen degradation. The collagen to MMP1 molar ratio used in this sample was 
calculated to be 1 collagen to 0.37X10-3 MMP1.   
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Figure 5. MMP1 collagen degradation assay. Collagen fibril solution was incubated 
with various concentrations of APMA-activated MMP1. The CBB staining demonstrated 
that MMP1 appears to degrade collagen type I in a dose-dependent manner. The non-
degraded collagen, including alpha-1, alpha-2, and multi-form (indicated by arrows and a 
bracket), appeared to be decreased and the degraded three quarters and one quarter 
collagen fragments (indicated by arrows) appeared to be increased as MMP1 
concentration was increased. The control sample of collagen without MMP1 (lane 1) 
showed only non-degraded collagen. This experiment was performed three times (n = 3) 
and a representative image was shown.  
 
 
It has been reported that recombinant decorin core protein inhibited MMP1-
mediated collagen type I degradation (Geng et al., 2006). SYI peptide is a synthetic 
peptide derived from decorin binding sites for collagen type I. It was demonstrated that 
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SYI peptide bound to collagen type I and competed with decorin core protein for the 
same collagen binding site (Kalamajski et al., 2007), the dose-dependent effect of SYI 
peptide on MMP1-mediated collagen type I degradation was investigated. Samples of     
2 µM collagen type I were incubated with various concentrations of SYI peptide or its 
scrambled peptide (0.006, 0.02, 0.05, and 0.17 mM). After incubation of collagen with 
each peptide overnight, the samples were further incubated with 76 nM of MMP1 to 
allow the degradation of collagen. The samples were then loaded on SDS-PAGE. To 
visualize proteins, including collagen and its degradation fragments, SDS-PAGE was 
stained with CBB (Figure 6 A). The non-degraded collagen in each sample, including 
alpha-1 chain, alpha-2 chain, and the multi-form collagen, was quantified using ImageJ 
software program as shown in Figure 6 B. The intensity of non-degraded collagen 
obtained from the control sample, in which collagen alone was loaded on SDS-PAGE 
(Figure 6 A, lane 1), was considered as the total collagen. The percentage of the non-
degraded collagen to the total amount of collagen was calculated for each sample. The 
percentage of non-degraded collagen for the samples were compared to evaluate the 
extent of collagen degradation. Statistical analysis was performed using one-way 
ANOVA. The results showed that only non-degraded collagen bands were observed in 
the absence of MMP1 incubated with collagen (Figure 6 A, lane 1). There were no 
collagen bands detected when collagen was treated with MMP1 in the absence of SYI 
peptide (Figure 6 A, lane 2), suggesting that collagen was completely degraded by 
MMP1. Non-degraded collagen including alpha-1, alpha-2, and multi-form was detected 
when collagen was incubated with various concentrations of SYI peptide and further 
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treated with MMP1 (Figure 6 A, lane 3-6). As SYI peptide concentration was increased, 
the amount of non-degraded collagen appeared to be increased. Non-degraded collagen 
including alpha-1, alpha-2, and multi-form was also detected when collagen was 
incubated with various concentrations of the scrambled peptide and further treated with 
MMP1 (Figure 6 A, lane 7-10). Although the concentration of the scrambled peptide was 
increased, the amount of non-degraded collagen did not appear to be increased. The 
percentage of non-degraded collagen was compared between samples with SYI peptide 
(Figure 6 A, lanes 3-6) and that without any peptide (Figure 6 A, lane 2). There was no 
statistical difference between the percentage of non-degraded collagen in the presence of 
SYI peptide and that in the absence of any peptides (Figure 6 C). There was no statistical 
difference of the percentage of non-degraded collagen among samples at any SYI peptide 
concentration (Figure 6 C). Additionally, the percentage of non-degraded collagen was 
compared between samples with SYI peptide (Figure 6 A, lane 3-6) and those with the 
scrambled peptide (Figure 6 A, lane 7-10). The results showed that there was no 
statistical difference between the percentage of non-degraded collagen in the presence of 
SYI peptide and that in the presence of the scrambled peptide at any peptide 
concentration tested (Figure 6 C). In conclusion, the data demonstrated that there was no 
specific effect of SYI peptide on MMP1-mediated collagen degradation.  
The scrambled peptide was made based on Peptide2.0 software program. The 
function of the scrambled peptide needs to be verified by a specific biological assay. The 
results showed that non-degraded collagen including alpha-1, alpha-2, and multi-form 
was detected when collagen was incubated with various concentrations of the scrambled 
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peptide and further treated with MMP1 (Figure 6 A, lanes 7-10). The percentage of non-
degraded collagen was compared between samples with the scrambled peptide (Figure 6 
A, lanes 7-10) and that without any peptides (Figure 6 A, lane 2). There was no statistical 
difference between the percentage of non-degraded collagen in the presence of the 
scrambled peptide and that in the absence of any peptides (Figure 6 C). Although there 
was no statistical difference, incubation of collagen with the scrambled peptide appeared 
to inhibit the collagen degradation to some extent as compared to the degradation of 
collagen in absence of any peptides (Figure 6 A, lane 2). The scrambled peptide did not 
seem to function as a control peptide for SYI peptide in this assay. 
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A                                                                                             B 
 
C 
 
Figure 6. The effect of the SYI peptide and its scrambled peptide at lower 
concentrations on MMP1-mediated collagen degradation. (A). Samples of collagen 
fibril solution were incubated with various concentrations of SYI peptide and the 
scrambled peptide. APMA-activated MMP1 was then added to the samples. Samples 
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containing collagen only and collagen with MMP1 in the absence of any peptides were 
prepared as controls. The red box indicates non-degraded collagen that was quantified to 
compare the extent of collagen degradation. This experiment was performed three times 
(n = 3), and a representative image was shown. (B). Schematic image demonstrating the 
method to quantify the intensity of non-degraded collagen, including alpha-1 (N-D col 
a1), alpha-2 (N-D col a2), and multi-forms of collagen, using Image J software. (C). A 
bar graph demonstrating the percentage of non-degraded collagen relative to the total 
amount of collagen for collagen samples incubated with various SYI peptide 
concentrations, incubated with the same concentrations of the scrambled peptide, and the 
control sample in which collagen was not incubated with any peptide. The values are 
shown as the mean +/- S.D. Statistical analysis was performed and there was no statistical 
difference between the percentage of non-degraded collagen in the presence of SYI 
peptide and that in the absence of any peptides (P value < 0.05). There was also no 
statistical difference of the percentage of non-degraded collagen among samples at any 
SYI peptide concentration (P value < 0.05). There was also no statistical difference 
between the percentage of non-degraded collagen in the presence of SYI peptide and that 
in the presence of the scrambled peptide at any peptide concentration tested (P value < 
0.05). 
 
 
As the previous results showed no effect of SYI peptide on MMP1-mediated 
collagen degradation, the effect of higher concentrations of SYI peptide on MMP1-
mediated collagen degradation was investigated. Samples of 2 µM collagen type I were 
incubated with various concentrations of SYI peptide or its scrambled peptide (0.25, 0.5, 
1, and 2 mM). After incubation of collagen with each peptide overnight, the samples 
were further incubated with 76 nM of MMP1 and visualized with CBB in the same 
manner as previously described (Figure 7 A). The non-degraded collagen in each sample, 
was quantified in the same manner as in Figure 6 B, and the percentage of the non-
degraded collagen to the total amount of collagen was calculated and compared to 
evaluate the extent of collagen degradation. The results showed high level of non-
degraded collagen bands in the absence of MMP1 incubated with collagen (Figure 7, lane 
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1). The level of non-degraded collagen bands was reduced when collagen was treated 
with MMP1 in the absence of SYI peptide (Figure 7 A, lane 2) as compared to collagen 
not treated with MMP1 (Figure 7, lane 1), suggesting that most collagen was degraded by 
MMP1. The level of non-degraded collagen bands appeared to be increased when 
collagen was incubated with various concentrations of SYI peptide and further treated 
with MMP1 (Figure 7 A, lane 3-6), suggesting that SYI peptide seemed to inhibit 
collagen degradation by MMP1. As SYI peptide concentration was increased, the extent 
of non-degraded collagen appeared to be increased. The percentage of non-degraded 
collagen was compared between the samples with SYI peptide (Figure 7 A, lanes 3-6) 
and that without any peptides (Figure 7 A, lane 2). There was no statistical difference 
between the percentage of non-degraded collagen in the presence of SYI peptide and that 
in the absence of any peptides (Figure 7 B). There was no statistical difference of the 
percentage of non-degraded collagen among samples at any SYI peptide concentration 
tested (Figure 7 B). In conclusion, the data demonstrated that there was no effect of 
higher concentrations of SYI peptide on MMP1-mediated collagen degradation.  
The results showed that non-degraded collagen was not detected when collagen 
was incubated with the least concentration of the scrambled peptide (0.25 mM) and 
further degraded by MMP1 (Figure 7 A, lane 7). The extent of non-degraded collagen 
appeared to be almost at a similar level when collagen was incubated with 0.5 or 1 mM of 
the scrambled peptide (Figure 7 A, lanes 8 and 9). When collagen was incubated with 2 
mM of the scrambled peptide (Figure 7 A, lane 10), the extent of non-degraded collagen 
appeared to be greater than that when collagen was incubated without any peptides 
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(Figure 7 A, lane 2). Statistical analysis was not performed because the experiment with 
the scrambled peptide was done only one time.  
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Figure 7. The effect of higher concentrations of SYI and its scrambled peptide on 
MMP1-mediated collagen degradation. (A). Samples of collagen fibril solution were 
incubated with higher concentrations of SYI peptide and the scrambled peptide. APMA-
activated MMP1 was then added to the samples. Samples containing collagen only and 
collagen with MMP1 in the absence of any peptides were prepared as controls. The red 
box indicates non-degraded collagen that was quantified to compare the extent of 
collagen degradation. N-D col a1, non-degraded collagen alpha-1; N-D col a2, non-
degraded collagen alpha-2. This experiment was performed three times (n = 3), and a 
representative image was shown. (B). A bar graph demonstrating the percentage of non-
degraded collagen relative to the total amount of collagen for samples in which collagen 
was incubated with various SYI peptide concentrations and the control sample in which 
collagen was not incubated with any peptide. The values are shown as the mean +/- S.D. 
Statistical analysis was performed and there was no statistical difference between the 
percentage of non-degraded collagen in the presence of SYI peptide and that in the 
absence of any peptides (P value < 0.05). There was also no statistical difference of the 
percentage of non-degraded collagen among samples with any SYI peptide concentration 
tested (P value < 0.05). Statistical analysis was not performed because the experiment 
with the scrambled peptide was done only one time. 
 
 
Biotin Affinity Chromatography to Identify Collagen Sequence that Binds SYI 
Peptide 
Our previous results (Figures 6 and 7) demonstrated no inhibitory effect of SYI 
peptide on MMP1-mediated collagen degradation. In this set of experiments the aim was 
to investigate SYI peptide binding to collagen. 
Biotin affinity chromatography was used to identify whether SYI peptide binds to 
collagen and to detect the collagen fragment that binds SYI peptide. Subsequently, the 
amino acid sequence of the collagen fragment was planned to be identified by mass 
spectrometry.  
A control experiment was done initially to evaluate the binding of biotin-SYI 
peptide to non-degraded collagen fibril solution in streptavidin sepharose packed 
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columns. First, the column was loaded with biotin-SYI peptide to allow the biotin and 
streptavidin binding. Then, non-degraded collagen fibril solution was loaded on the 
column to allow biotin-SYI peptide and collagen binding (Figure 8 A). Subsequently, the 
column was centrifuged and the collagen flow-through was collected (Figure 8 A, col), 
followed by washing the column four times and collecting the flow-through each time the 
column was washed (Figure 8 A, W1-W4). Finally, the column was eluted three times, 
collecting the elution each time (Figure 8 A, E1-E3). Two control columns were used in 
this experiment - a column loaded with collagen fibril solution alone (Figure 8 B) and a 
column loaded with biotin-scrambled peptide instead of biotin-SYI peptide (Figure 8 C). 
The same proportional amount of the collagen flow-through, the washing flow-through, 
and the elution were loaded on SDS-PAGE. To visualize proteins, including collagen, 
SDS-PAGE was stained with CBB. The results showed that non-degraded collagen alpha 
1 and alpha 2 were detected when biotin-SYI peptide and non-degraded collagen fibrils 
solution were used (Figure 8 A, E1-E3), indicating that biotin-SYI peptide bind to 
collagen fibrils. There were no collagen bands observed in the elution of the control 
column loaded with non-degraded collagen only (Figure 8 B, E1-E3), thus confirming the 
specificity of biotin-SYI peptide and collagen binding observed. There were non-
degraded collagen alpha 1 and alpha 2 bands observed in the elution of the control 
column loaded with biotin-scrambled peptide (Figure 8 C, E1-E3). However, the amount 
of collagen in the elution appeared to be less than the amount of collagen observed in the 
washing flow-through from this column (Figure 8 C, W1-W4). Therefore, the collagen 
bands observed in the elution of this column suggest lower peptide/collagen binding 
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compared to SYI peptide. These data indicate that non-degraded collagen fibrils bind to 
biotin-SYI peptide, and could be separated and visualized with a low degree of specificity 
using the streptavidin sepharose packed columns.   
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A                                                                                B 
    
C 
 
Figure 8. Biotin affinity chromatography to identify non-degraded collagen fibril 
that binds to SYI peptide. (A). A column was loaded with biotin-SYI peptide, then with 
collagen fibril solution. The column was centrifuged and non-bound collagen flow-
through was collected. Then, the column was washed four times with the washing buffer, 
and eluted three times with 0.1 M glycine, 2 M urea, pH 2.9. The washing flow-through 
was collected from each washing time. The same proportion of the unbound collagen 
flow-through, each washing flow-through, and each elution was loaded on SDS-PAGE. 
SDS-PAGE was stained with CBB. M, marker; Col, flow-through of unbound collagen; 
W1, flow-through of the first washing; W2, flow-through of the second washing; W3, 
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flow-through of the third washing; W4, flow-through of the fourth washing; E1, the first 
elution; E2, the second elution; E3, the third elution. (B). A control column loaded with 
collagen fibril solution only. (C). A control column loaded with biotin-scrambled peptide 
instead of biotin-SYI peptide and then with collagen fibril solution. All experiments in A, 
B, and C were performed three times (n = 3), and representative images were shown. 
 
 
In order to identify the collagen sequence that binds to SYI peptide, biotin affinity 
chromatography was first used to separate the MMP1-degraded collagen fragment that 
SYI peptide binds to. Biotin-SYI peptide was loaded on the column to allow streptavidin 
and biotin-SYI peptide binding. Then, MMP1-degraded collagen solution was incubated 
in the column to allow biotin-SYI peptide and collagen fragment binding. Subsequently, 
the column was centrifuged, washed, and eluted, and applied on SDS-PAGE in the same 
manner as described above (Figure 9 A). Two control columns were used in this 
experiment - a column loaded with MMP1-degraded collagen solution only (Figure 9 B) 
and a column loaded with biotin-scrambled peptide instead of biotin-SYI peptide (Figure 
9 C). The results showed that no positively stained bands were observed when the 
column was loaded with biotin-SYI peptide and then with MMP1-degraded collagen 
solution (Figure 9 A, E1-E2). There were no positively stained bands observed in the 
elution of the two control columns, i.e. the column loaded with MMP1-degraded collagen 
solution only (Figure 9 B, E1-E3) and the column loaded with biotin-scrambled peptide 
(Figure 9 C, E1-E2). In conclusion, when MMP1 was used as a collagen-degrading 
enzyme, the collagen fragment that biotin-SYI peptide binds to was not detected using 
streptavidin sepharose packed columns.   
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A                                                                      B 
 
C 
 
Figure 9. Biotin affinity chromatography to identify the collagen fragment that 
binds to SYI peptide using MMP1 as a collagen-degrading enzyme. (A). A column 
loaded with biotin-SYI peptide then with MMP1-degraded collagen solution. The column 
was centrifuged and non-bound collagen flow-through was collected. Then, the column 
was washed three times with the washing buffer, and eluted three times with 0.1 M 
glycine, 2 M urea, pH 2.9. The washing flow-through was collected from each washing 
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time. The same proportion of the unbound collagen flow-through, each washing flow-
through, and each elution was loaded on SDS-PAGE. SDS-PAGE was stained with CBB. 
M, marker; Col, flow-through of unbound collagen fragment; W1, flow-through of the 
first washing; W2, flow-through of the second washing; W3, flow-through of the third 
washing; E1, the first elution; E2, the second elution; E3, the third elution. (B). A control 
column loaded with MMP1-degraded collagen solution only. (C). A control column 
loaded with biotin-scrambled peptide instead of biotin-SYI peptide and then with MMP1-
degraded collagen solution. All experiments in A, B, and C were performed two times (n 
= 2), and representative images were shown. 
 
 
As we could not detect any MMP1-degraded collagen fragments that biotin-SYI 
peptide binds to, degrading collagen by another enzyme, producing different collagen 
fragments, may allow the binding of the degraded collagen fragments to SYI peptide and 
subsequent separation by biotin affinity chromatography. Trypsin was used as an 
alternative collagen-degrading enzyme. First, collagen to trypsin ratio was optimized by 
incubating samples of collagen type I with various concentrations of trypsin (0.43, 0.86, 
and 1.72 µM). These concentrations were selected based on previous studies in the 
literature (Dung et al, 1994). Collagen alone without trypsin served as a control. Then, 
the samples were loaded on SDS-PAGE. To visualize proteins, including collagen and its 
degraded fragments, SDS-PAGE was stained with CBB (Figure 10). Collagen alpha-1 
chain, collagen alpha-2 chain, and multi-form collagen bands were detected when 
collagen was incubated with the two lowest trypsin concentrations and not when collagen 
was incubated with the highest trypsin concentration. When collagen type I samples were 
incubated with various concentrations of trypsin (Figure 10, lanes 2-4), positively stained 
bands migrated at lower molecular weights than non-degraded collagen alpha-2 band 
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were detected, indicating degradation of collagen by trypsin. As trypsin concentration 
was increased, the amount of non-degraded collagen appeared to be decreased and the 
amount of degraded collagen fragments appeared to be increased. In the control sample in 
which collagen was not incubated with trypsin, only collagen alpha-1 chain, collagen 
alpha-2 chain, and multi-form collagen bands were detected (Figure 10, lane 1). The data 
demonstrated that trypsin appeared to degrade collagen type I in a dose-dependent 
manner. When collagen was incubated with 0.86 µM trypsin (Figure 10, lane 3), less non-
degraded collagen bands were detected compared to when collagen was incubated with 
0.43 µM trypsin (Figure 10, lane 2) and more degraded collagen fragment bands were 
detected compared to when collagen was incubated with 1.72 µM trypsin (Figure 10, lane 
4). Therefore, a trypsin to collagen molar ratio of 1:2 (Figure 10, lane 3) was selected to 
be used for subsequent experiments. This ratio exhibited adequate collagen degradation 
and clearly visualized trypsin-degraded collagen fragments by CBB-stained SDS-PAGE.   
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Figure 10. Degradation of collagen with trypsin. Collagen solution was incubated with 
different concentrations of trypsin. The data demonstrated that trypsin degraded collagen 
in a dose-dependent manner. The non-degraded collagen, including alpha-1 (N-D col. 
a1), alpha-2 (N-D col. a2), and multi-form, appeared to be decreased and the degraded 
collagen fragments (indicated by brackets) appeared to be increased as trypsin 
concentration was increased. The control sample of collagen without trypsin (lane 1) 
showed only non-degraded collagen. This experiment was performed once (n = 1). 
 
 
Subsequently, in order to identify trypsin-degraded collagen fragments that may 
bind to biotin-SYI peptide, biotin-SYI peptide was loaded on streptavidin sepharose 
packed column. Trypsin-degraded collagen solution was then incubated in the column to 
allow biotin-SYI peptide and collagen fragment binding. The column was centrifuged, 
washed, eluted, and applied on SDS-PAGE in the same manner as described above 
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(Figure 11 A). Five controls were used in this experiment - a column loaded with biotin-
SYI peptide and then with non-degraded non-fibrillized collagen solution only (Figure 11 
B), a column loaded with non-degraded non-fibrillized collagen solution only (Figure 11 
C), a column loaded with trypsin-degraded collagen solution only (Figure 11 D), a 
column loaded with biotin-scrambled peptide instead of biotin-SYI peptide and then with 
the prepared trypsin-degraded collagen solution (Figure 11 E), and a column loaded with 
biotin-SYI peptide and then with trypsin alone, without collagen (Figure 11 F). All the 
control columns were centrifuged, washed, and eluted in the same manner. The results 
showed that no positively stained degraded collagen fragments were observed in the 
elution of the column loaded with biotin-SYI peptide and then with trypsin-degraded 
collagen solution (Figure 11 A, E1-E3). Collagen alpha-1 and alpha-2 bands were 
detected in the control column loaded with biotin-SYI and then with non-degraded non-
fibrillized collagen solution (Figure 11 B, E1-E2). However, the amount of collagen in 
the elution was less than that observed in the washing flow-through of this column 
(Figure 11 B, W1-W3), indicating that collagen monomer did not bind to biotin-SYI 
peptide. Collagen alpha-1 and alpha-2 bands were also detected in the control column 
loaded with non-degraded non-fibrillized collagen solution only (Figure 11 C, E1-E3); 
however, these bands do not indicate binding of non-degraded collagen for the same 
reason described above. There were no collagen bands observed in the elution of the 
other control columns, loaded with trypsin-degraded collagen solution only (Figure 11 D, 
E1-E3), loaded with biotin-scrambled peptide then with trypsin-degraded collagen 
solution (Figure 11 E, E1-E3), and loaded with biotin-SYI peptide and then with trypsin 
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alone (Figure 11 F, E1-E3), confirming the absence of any non-specific binding other 
than biotin-SYI peptide and collagen binding. In conclusion, collagen fragment that may 
bind to biotin-SYI peptide was not detected using streptavidin sepharose packed columns 
when trypsin was used as a collagen-degrading enzyme.   
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Figure 11. Biotin affinity chromatography to identify collagen fragment that binds 
to SYI peptide using trypsin as a collagen-degrading enzyme. (A). A column loaded 
with biotin-SYI peptide then with trypsin-degraded collagen solution. The column was 
centrifuged and unbound collagen flow-through was collected. Then, the column was 
washed four times with the washing buffer, and eluted three times with 0.1 M glycine, 2 
M urea, pH 2.9. The washing flow-through was collected from each washing time. The 
same proportion of the unbound collagen flow-through, each washing flow-through, and 
each elution was loaded on SDS-PAGE. SDS-PAGE was stained with CBB. M, marker; 
Col, flow-through of unbound collagen fragment; W1, flow-through of the first washing; 
W2, flow-through of the second washing; W3, flow-through of the third washing; W4, 
flow-through of the fourth washing; E1, the first elution; E2, the second elution; E3, the 
third elution. (B). A control column loaded with biotin-SYI peptide and then with non-
degraded non-fibrillized collagen solution. (C). A control column loaded with non-
degraded non-fibrillized collagen solution only. (D). A control column loaded with 
trypsin-degraded collagen solution only. (E). A control column loaded with biotin-
scrambled peptide instead of biotin-SYI peptide and then with prepared trypsin-degraded 
collagen solution. (F). A control column loaded with biotin-SYI peptide and then with 
trypsin alone. All experiments in A, B, C, D, E, and F were performed only once (n = 1). 
 
 
MMP1 Activity Assay 
Initially, we thought that SYI peptide inhibited MMP1-mediated collagen 
degradation. However, the statistical analysis of our previous data showed no effect of 
SYI peptide on MMP1-mediated collagen degradation (Figure 6; Figure 7). The purpose 
of this experiment was to investigate whether SYI peptide inhibited MMP1-mediated 
collagen degradation as a competitive substrate of MMP1. MMP1 activity in the presence 
of SYI peptide or its scrambled peptide was assessed using a MMP1 activity assay kit. A 
chromogenic thiopeptide substrate was employed as a synthetic substrate for MMP1. The 
optical density (OD) of degrading the thiopeptide substrate by MMP1 was measured 
every three minutes. The enzymatic reaction by MMP1 alone served as a positive control, 
while the enzymatic reaction in the presence of the known MMP1 inhibitor, N-Isobutyl-
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N-(4-methoxyphenylsulfonyl)-glycylhydroxamic acid (NNGH), served as another 
control. The dose of SYI peptide used in the collagen degradation assay (Figure 6; Figure 
7) was tested in this MMP1 activity assay. After obtaining the OD values, the initial rate 
of the reaction was calculated using the curve of absorbance versus time, expressed as 
OD/min. (Figure 12) (Table 2). The rate of the MMP1 enzymatic reaction was high in the 
control where there was no peptide (indicated by the gray dot curve, Figure 12 A and 
Figure 12 B), while that of the MMP1 enzymatic reaction in the presence of NNGH was 
markedly suppressed (indicated by the orange dot curve, Figure 12 A and Figure 12 B). 
On the contrary, the rate of the MMP1 enzymatic reaction was essentially unaffected by 
SYI peptide (Figure 12 A) and by the scrambled peptide (Figure 12 B) at the 
concentrations tested. Statistical analysis was performed using one-way ANOVA and the 
results showed that there was no statistical difference between MMP1 activities without 
SYI peptide and with SYI peptide at any of the concentrations tested (Figure 12 C). There 
was also no statistical difference between MMP1 activities with SYI peptide and with the 
scrambled peptide at any of the concentrations tested (Figure 12 C). Therefore, the results 
clearly demonstrated that SYI peptide did not affect MMP1 activity and was not a 
competitive substrate for MMP1.   
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Figure 12. MMP1 activity assay. (A-B). A chromogenic thiopeptide was degraded by 
MMP1 in the presence of various SYI peptide concentrations (A) or scrambled peptide 
(B). The optical density (OD) of the samples was recorded at 420 nm every 3 min. This 
experiment was performed three times (n = 3). Data shown was for one representative 
assay. (C). Quantitative analysis of the MMP1 activity assay. The activity of MMP1 was 
measured as the initial rate of the reaction, represented by the slope of the best-fit line of 
the plotted points for the straight region of the reaction curve. The values are shown as 
mean +/- S.D. based. Statistical analysis was performed and there was no statistical 
difference between MMP1 activities without SYI peptide and with SYI peptide at any 
concentrations tested (P value < 0.05). There was also no statistical difference between 
MMP1 activities with SYI peptide and with the scrambled peptide at any concentrations 
tested (P value < 0.05). 
.  
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 Average MMP1 activity (OD 420 
nm/min.) 
Control inhibitor (NNGH) 4.46 X 10-3 ± 0.31X 10-3 
Control, no peptide 18.46 X 10-3 ± 3.85 X 10-3 
Scrambled peptide (mM) 0.7 15.75 X 10-3 ± 3.37 X 10-3 
0.23 14.45 X 10-3 ± 0.37 X 10-3 
0.07 18.51 X 10-3 ± 3.57 X 10-3 
0.023 18.55 X 10-3 ± 3.35 X 10-3 
SYI peptide (mM) 0.7 12.91 X 10-3 ± 2.91 X 10-3 
0.23 16.46 X 10-3 ± 3.19 X 10-3 
0.07 17.71 X 10-3 ± 3.51 X 10-3 
0.023 18.45 X 10-3 ± 3.21 X 10-3 
Table 2. Average MMP1 Activity. The values are shown as the mean +/- S.D. based on 
three experiments (n = 3).  
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DISCUSSION 
 
The Effect of SYI Peptide on MMP1-Mediated Collagen Degradation 
The peptide SYIRIADTNIT (SYI peptide) is derived from decorin. It is located at 
LRR 6 and encompasses Arg-207 and Asp-210, which are important for collagen binding 
(Kalamajski et al., 2007). It has been previously reported that SYI peptide inhibited 
decorin-collagen interaction, which showed the capacity of SYI peptide to bind collagen 
type I(Kalamajski et al., 2007). It also has been reported that decorin inhibited MMP1-
mediated collagen degradation in vitro (Geng et al., 2006). Consequently, we speculated 
that SYI peptide may inhibit MMP1-mediated collagen degradation. However, our data 
showed that there was no statistical difference between the extent of collagen degradation 
by MMP1 in the presence and absence of SYI peptide; hence we concluded there was no 
effect of SYI peptide on MMP1-mediated collagen degradation (Figures 6 and 7). There 
might be some pitfalls in the current study regarding the data. First, MMP1 was not 
reproducibly active in each experiment. The control experiment was successful to show 
degradation of collagen to three quarters and one quarter collagen fragments (Figure 5); 
however, the subsequent experiments, which investigated the effect of SYI peptide, were 
not reproducible, showing complete collagen degradation without any positively stained 
CBB collagen degraded-fragments in the control sample where collagen was incubated 
with MMP1 without the presence of any peptide (Figure 6, lane 2), while some collagen 
degraded bands were detected in the same control of other experiments (Figure 7, lane 2). 
The pattern of collagen degradation was also different between the experiments, which 
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made it difficult to identify a consistent read out. Second, the percentage of non-degraded 
collagen relative to the total amount of collagen was used as the quantitative read out for 
the extent of collagen degradation. However, this may not be the appropriate read out to 
show the inhibitory effect of SYI peptide on MMP1-mediated collagen degradation. 
There are a couple of alternative read outs that may serve as a better evaluation criterion 
that were not considered in the present study. These read outs could be the degraded 
collagen three quarters and/or one quarter fragments. The amount of degraded collagen 
fragments produced in the control experiment (Figure 5) appeared to serve as a more 
reliable readout compared to the remaining non-degraded collagen used in the current 
study. However, the degraded collagen fragments could not be used as a read out in the 
current study because of the non-reproducibility in MMP1 activity between the 
experiments.  
Although the effect of SYI peptide on MMP1-mediated collagen degradation 
needs to be further studied, the reason the results suggest that there is no effect of SYI 
peptide on MMP1-mediated degradation may be explained as follows. Decorin core 
protein is a large molecule consisting of 354 amino acids. It is approximately 40 kDa in 
size. It has been reported that decorin inhibited MMP1-mediated collagen type I 
degradation by binding to collagen, possibly at or near the MMP1 cleavage site, thus 
masking the cleavage site and limiting access of MMP1 to its collagen cleavage site 
(Geng et al, 2006). It was reported that collagenases catalyze the cleavage of collagen 
types I peptide bond between Gly775 and Ile776 (Lauer-Fields et al, 2002). It has been 
reported also that a major binding site of decorin core protein corresponded to alpha-1 
  56 
cymongen bromide 6 collagen peptide (CB6) (Keene et al, 2001). CB6 collagen peptide 
was reported to consist of 192 amino acids beginning from around the amino acid 
corresponding to the site 819 (Henkel et al, 2007). Based on these reports, the MMP1 
cleavage site appeared to be not far from the decorin binding site on collagen. On the 
other hand, SYI peptide consists of eleven amino acids and is 1,266.4 Da in size. 
Although SYI peptide was derived from the active collagen-binding site of decorin, it is a 
small peptide compared to decorin. This suggests that even though decorin and SYI 
peptide bind to the same region in collagen, the region of decorin which is not 
responsible for collagen binding may mask MMP1 cleavage site while SYI peptide may 
not. Several structural studies showed the binding and processing mechanisms of MMP1 
against collagen type I (Arnold et al., 2011; Manka et al., 2012). However, it is still not 
clear whether the binding region of MMP1 within collagen type I overlaps with that of 
decorin. Further studies are still needed to conclude how decorin inhibits MMP1-
mediated collagen degradation.  
Additionally, a crystal structure of a decorin-collagen complex suggests that 
decorin has multiple binding sites to collagens, showing the complexity of the interaction 
(Orgel, Eid, Antipova, Bella, & Scott, 2009). The existence of multiple low-affinity 
binding sites of decorin to collagen has also been suggested in other previous studies 
(Kalamajski et al., 2007; Svensson et al., 1995). Therefore, if decorin interferes with 
MMP1-mediated collagen degradation and SYI peptide does not, that might be due to a 
possible existence of multiple binding sites of decorin to collagen. This may be another 
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reason why our data did not show any effect of SYI peptide on MMP1-mediated collagen 
degradation. 
 
Biotin Affinity Chromatography to Identify the Collagen Fragment that Binds to 
SYI Peptide 
Identifying the collagen sequence that binds to SYI peptide will support our 
previous results that showed no inhibitory effect of SYI peptide on MMP1-mediated 
collagen degradation. Biotin affinity chromatography was used to separate the collagen 
fragment that binds SYI peptide. The amino acid sequence of the separated collagen 
fragment that bound SYI peptide was planned to be identified by mass spectrometry. 
Initially, MMP1 was used as a collagen-degrading enzyme. There were no degraded 
collagen fragments identified when biotin-SYI peptide was used (Figure 9 A). However, 
non-degraded collagen fibrils were found as a biotin-SYI peptide-binding protein (Figure 
8 A). These results indicated that MMP1 could cleave collagen-SYI peptide binding site, 
thus preventing their binding. Another explanation might be as follows. If the amount of 
collagen loaded on the column was insufficient to detect the collagen fragment that 
bound biotin-SYI peptide, degraded collagen fragment might indeed be present, but 
might not be found because the staining level of the collagen fragment was below the 
detection limit for CBB staining. Another possibility is that the collagen fragment that 
bound to biotin-SYI peptide was too small to be detected by SDS-PAGE and it migrated 
out or to the bottom of SDS-PAGE. 
  58 
Secondly, trypsin was used as a collagen-degrading enzyme to digest collagen 
differently from MMP1, aiming to separate the degraded collagen fragment that may bind 
to biotin-SYI peptide using biotin affinity chromatography. The results showed no 
trypsin-degraded collagen fragment that bound to biotin-SYI peptide was separated 
(Figure 11 A). Non-degraded, non-fibrillized collagen was also not separated (Figure 11 
B). These results may suggest that the amount of collagen loaded on the column was not 
sufficient to show the separated non-degraded collagen in the control column. However, 
if we assume that the amount of collagen loaded on the column was sufficient, the data 
may also indicate that SYI peptide might not bind to non-fibrillized collagen, and 
collagen fibril form may be crucial for SYI peptide-collagen binding. Moreover, in the 
current study, non-fibrillized collagen was degraded by trypsin to generate the collagen 
fragments solution that was loaded on the streptavidin sepharose packed column, aiming 
to separate the degraded collagen fragment that may bind to biotin-SYI peptide. Since the 
data suggest that collagen fibril form may be crucial for SYI peptide-collagen binding, 
degrading fibril collagen by trypsin instead on non-fibrillized collagen used in the current 
study may be considered in future studies to separate the degraded collagen fragment that 
may bind biotin-SYI peptide. To detect the collagen fragment that binds SYI peptide, the 
method described by Keene (2001) to identify the cymongen bromide (CB)-digested 
collagen fragment that binds to decorin core protein might be useful. It has been reported 
that a major binding site of decorin core protein corresponded to alpha-1 CB6 collagen 
peptide. A photoaffinity labeling and cross-linking approach was reported to identify 
alpha-1 CB6 collagen peptide as a decorin binding site. Decorin core protein was 
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radiolabeled with 125I and derivatized with sulfosuccinimidyl-2-[p-
azidosalicylamido]ethyl-1,3-dithiopropionate (SASD). Derivatized decorin was then 
allowed to bind to collagen fibrils. Decorin and collagen was further covalently cross-
linked by ultraviolet light; then, the covalent linkage was severed by reduction with b-
mercaptoethanol, resulting in tagging of the decorin-binding site on collagen. The 
labelled collagen was cleaved with CB and subjected to SDS-PAGE, autoradiography, 
and CBB staining. Similar methods may lead to successful identification of the collagen 
fragment that binds SYI peptide, and decorin core protein could be used as a positive 
control in this experimental plan.  
Alternatively, modifying the experimental procedure used in the current study 
may lead to successful separation of the collagen fragment that binds SYI peptide. For 
example, more sensitive staining techniques may be used, including silver staining, which 
has higher sensitivity than CBB staining and is able to detect less than 1 ng of protein. 
Silver staining is compatible with mass spectrometry analysis. Fluorescent stains could 
also be used, such as Sypro Ruby. The sensitivity of Sypro Ruby staining is as good as or 
better than silver staining techniques. It interacts non-covalently with proteins. Thus, 
mass spectrometry data can be obtained immediately after staining without modification 
steps.  
Moreover, if the separated collagen fragment that binds SYI peptide is too small 
to be detected by SDS-PAGE and CBB staining, additional purification methods to 
further purify the elution from biotin affinity column prior to mass spectrometry analysis 
may be used. Reversed-phase HPLC is a widely used protein and peptide separation 
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technique with high resolving capability. It utilizes the attachment of peptides and 
proteins to a highly hydrophobic particle surface. Protein or peptide is retained by 
adsorption to that surface until desorbed and eluted by specific concentration of organic 
solvent. The use of modified silica (C18) in the separation surface is particularly useful 
for the separation of small peptides and is usually the surface of choice for the separation 
of peptides resulting from protease digestion of proteins.  
 
The Effect of SYI Peptide on MMP1 Activity 
It was thought that SYI peptide inhibited collagen degradation by MMP1. 
However, the statistical analysis of the collagen degradation assays showed no effect of 
SYI peptide on MMP1-mediated collagen degradation. The effect of SYI peptide on 
MMP1 activity using a different substrate than collagen was studied to investigate 
whether SYI peptide inhibited MMP1-mediated collagen degradation as a competitive 
substrate or inhibitor of MMP1 or by sterically blocking the access of MMP1 to its 
collagen cleavage site. Our data showed that MMP1 activity was not affected by the 
presence of SYI peptide (Figure 12). These results are supported by two previous reports. 
The first report studied whether recombinant decorin could be acting as a competitive 
substrate for MMP1 and thereby inhibiting its activity towards collagen fibrils (Geng et 
al., 2006). The second report studied the susceptibility of human recombinant decorin to 
MMP1(Imai, Hiramatsu, Fukushima, Pierschbacher, & Okada, 1997). Both reports 
concluded that decorin was not digested by MMP1. Their results indicate that decorin is 
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not a competitive substrate for MMP1. However, decorin still could be an inhibitor for 
MMP1. 
Recombinant human MMP1, used in Figure 12, was purchased from Abcam 
(ab139443). The recombinant MMP1 protein was produced in HEK293 cells; it consists 
of amino acids Met1 to Asn469 and is fused with a polyhistidine tag at the C-terminus. In 
contrast, recombinant human MMP1 used in the collagen degradation assay (Figures 6 
and 7) was purchased from R&D systems. This MMP1 protein was produced in a mouse 
myeloma cell line; it is a pro-form consisting of amino acids Phe20 to Asn469 with no 
tag. Although MMP1 purchased from R&D systems has been investigated in the MMP1 
activity assay, the recombinant MMP1 was not activated under the condition tested. To 
be consistent with the previous data from the collagen degradation assay (Figures 6 and 
7), the effect of SYI peptide on the activity of MMP1 from R&D systems needs to be 
further studied.   
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